Table 3.
Meta-analysis of the response rate, PASI, adverse dermatological reactions (comparing ex-CHM with other therapies for psoriasis vulgaris treatment)
|
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.